Anakinra for palmoplantar pustulosis: results from a randomized, double-blind, multicentre, two staged, adaptive placebo controlled trial (APRICOT)

CONCLUSIONS: No evidence for superiority of anakinra was found. IL-1 blockade is not a useful intervention for the treatment of PPP.PMID:34411292 | DOI:10.1111/bjd.20653

Source: The British Journal of Dermatology - August 19, 2021 Category: Dermatology Authors: S Cro V R Cornelius A E Pink R Wilson A Pushpa-Rajah P Patel A Abdul-Wahab S August J Azad G Becher A Chapman G Dunnil A D Ferguson A Fogo S A Ghaffar J R Ingram S Kavakleiva E Ladoyanni J A Leman A E Macbeth A Makrygeoegou R Parslew A J Ryan A Sharma A R Source Type: research